General Dermatology

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.

Explore the top headlines of the week including insights from Terri Philips, MD, FAAP, innovations in wound healing, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ sNDA for roflumilast in pediatric AD, the current clinical and aesthetic applications of snail mucin, positive results from the CHE delgocitinib trial in China, and more.

This week, we feature top articles from our sister publications on recent clinical trials, practice management, and innovative technology.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the month including the expanding role of NPs and PAs, a guide to 2025 conferences, and expert insights from Paul Friedman, MD.

Review our content from the month of February that recognizes patients and clinicians with skin of color.

Learn more about the in-depth topics covered in the February 2025 print issue of Dermatology Times.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dermatology Times is looking back on the top stories in dermatology from the month of February.

Dermatology Times is recapping our top expert interviews from the month of February.

Well Revolution’s partnership with City Chemist highlights how telehealth can sustain small businesses and improve patient care.

Lead investigator Leon Kircik, MD, emphasized the need for collaboration between clinicians, technologists, and policymakers to maximize VR/AR’s potential.

This review of the latest dermatologic studies includes insights into comorbidities, innovative therapies, and ultrasound for HS.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

This collective initiative gives Mindy Haws, MD, and her team the ability to reach more women in a way that gives back and helps them succeed.

Researchers reported that propranolol initiation for infantile hemangiomas in pediatric patients is safe, with no significant complications, suggesting reduced need for intensive monitoring.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Mindy Haws, MD, spoke to Dermatology Times about the new videos, podcasts, and other resources LIMITLESS offers for women at all stages of their careers.

Explore the top headlines of the week including the expanding role of NPs and PAs, a clinician’s guide to chemical peels, and recently announced therapeutic updates.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ new seborrheic dermatitis initiative with Odell Beckham Jr., Zabalafin’s IND for atopic dermatitis, dupilumab as a potential BP treatment, and more.

This week, we feature top articles from our sister publications on women in health care, the relationship between the public and insurance companies, and more.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Geological particles can cause skin irritation, allergies, and long-term dermatological conditions.

A study found that 65.8% of US adults distrust their health care system’s use of AI, highlighting a need for better communication on AI tools.

A study found that vitiligo patients had a higher incidence of COVID-19 than those with psoriasis or atopic dermatitis.